2012 Aarkstore.com || Bipolar disorder (manic depression) – pipeline review, h2 2012

1. Aarkstore.com announces, The Latest market research report is available in
its vast collection:
Bipolar Disorder (Manic Depression) – Pipeline Review, H2
2012
You can also request for sample page of above mention reports on
sample@aarkstore.com
Summary
Global Markets Direct’s, Bipolar Disorder (Manic Depression) - Pipeline Review, H2
2012, provides an overview of the Bipolar Disorder (Manic Depression) therapeutic
pipeline. This report provides information on the therapeutic development for
Bipolar Disorder (Manic Depression), complete with latest updates, and special
features on late-stage and discontinued projects. It also reviews key players
involved in the therapeutic development for Bipolar Disorder (Manic Depression).
Bipolar Disorder (Manic Depression) - Pipeline Review, H2 2012 is built using data
and information sourced from Global Markets Direct’s proprietary databases,
Company/University websites, SEC filings, investor presentations and featured
press releases from company/university sites and industry-specific third party
sources, put together by Global Markets Direct’s team.
Note*: Certain sections in the report may be removed or altered based on the
availability and relevance of data for the indicated disease.
Scope
- A snapshot of the global therapeutic scenario for Bipolar Disorder (Manic
Depression).
- A review of the Bipolar Disorder (Manic Depression) products under development
by companies and universities/research institutes based on information derived

2. from company and industry-specific sources.
- Coverage of products based on various stages of development ranging from
discovery till registration stages.
- A feature on pipeline projects on the basis of monotherapy and combined
therapeutics.
Reasons to buy
- Identify and understand important and diverse types of therapeutics under
development for Bipolar Disorder (Manic Depression).
- Identify emerging players with potentially strong product portfolio and design
effective counter-strategies to gain competitive advantage.
Table of contents:
List of Tables 5
List of Figures 6
Introduction 7
Global Markets Direct Report Coverage 7
Bipolar Disorder (Manic Depression) Overview 8
Therapeutics Development 9
An Overview of Pipeline Products for Bipolar Disorder (Manic Depression) 9
Bipolar Disorder (Manic Depression) Therapeutics under Development by
Companies 11
Bipolar Disorder (Manic Depression) Therapeutics under Investigation by
Universities/Institutes 14
Late Stage Products 17
Comparative Analysis 17
Mid Clinical Stage Products 18
Comparative Analysis 18
Early Clinical Stage Products 19
Comparative Analysis 19
Pre-Clinical Stage Products 20
Comparative Analysis 20
Bipolar Disorder (Manic Depression) Therapeutics – Products under Development
by Companies 21

3. Bipolar Disorder (Manic Depression) Therapeutics – Products under Investigation
by Universities/Institutes 23
Companies Involved in Bipolar Disorder (Manic Depression) Therapeutics
Development 25
AstraZeneca PLC 25
List of Figures
List of Tables are also include.
For more related Reports Plz follow The link:
Pipeline Review, H2 2012
http://www.aarkstore.com/search/viewresults.asp?search=Pipeline Review, H2
2012&PubId=&pagenum=1
Acute Pain – Pipeline Review, H2 2012
Hemophilia – Pipeline Review, H2 2012
Dyslipidemia – Pipeline Review, H2 2012
Chronic Kidney Disease (Chronic Renal Failure) – Pipeline Review, H2 2012
Bipolar Disorder (Manic Depression) – Pipeline Review, H2 2012
Smoking Cessation – Pipeline Review, H2 2012
Acne And Related Disorders – Pipeline Review, H2 2012
Allergic Rhinitis – Pipeline Review, H2 2012

4. Systemic Lupus Erythematosus – Pipeline Review, H2 2012
Atherosclerosis – Pipeline Review, H2 2012
Search More Reports Related to This Category :
Pharmaceuticals and Healthcare
http://www.aarkstore.com/search/viewresults.asp?search=Pharmaceuticals and
Healthcare&PubId=&pagenum=1
For More details Plz do contact :
Aarkstore Enterprise
Lavanya
Phone:08149852585
Email: enquiry@aarkstore.com